Trials / Completed
CompletedNCT02758444
Effects of EED on Zn Absorption and Retention in Children From a MNP
Effects of Environmental Enteric Dysfunction (EED) on Zinc (Zn) Absorption and Retention in Young Children: Study 2 - Absorption of Zn From a Multi-micronutrient Powder (MNP)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Months – 24 Months
- Healthy volunteers
- Accepted
Summary
The overall objective is to determine the impact of EED on total daily zinc absorption of young Bangladeshi children (18-24 months of age) in an austere setting with high rates of diarrhea, stunting, and micro-nutrient deficiencies..
Detailed description
Participating children are screened for EED using the lactulose:mannitol ratio test and assigned to one of two groups: +EED or -EED. After assignment to one of the two groups, proposed subjects will be randomized to one of four supplement groups: Micronutrient powder (MNP) with 15 mg Zn, MNP with 10 mg Zn, MNP with 5 mg Zn, and MNP with 0 mg Zn. Children will receive the supplement once with a meal on Day 8 of the study. Absorption of zinc from the supplement and from other non-supplemented meals will be determined using zinc stable isotope technology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Micronutrient Powder (MNP) + 15 mg Zn | Children will have the supplement powder added to one meal on study day 1. Absorption of zinc from this meal will be measured using zinc stable isotope techniques. |
| DIETARY_SUPPLEMENT | MNP + 10 mg Zn | Same as above except MNP will contain 10 mg Zn |
| DIETARY_SUPPLEMENT | MNP + 5 mg Zn | Same as above except MNP will contain 5 mg Zn |
| DIETARY_SUPPLEMENT | MNP without Zn | Same as above except MNP will not contain Zn |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2018-03-01
- Completion
- 2019-02-01
- First posted
- 2016-05-02
- Last updated
- 2019-07-05
Locations
2 sites across 2 countries: United States, Bangladesh
Source: ClinicalTrials.gov record NCT02758444. Inclusion in this directory is not an endorsement.